Volunteers receiving a second dose of the Pfizer-BioNTech vaccine remained more than 90% protected against symptomatic COVID-19.
Volunteers receiving a second dose of the Pfizer-BioNTech vaccine remained more than 90% protected against symptomatic COVID-19.
Please to comment